Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) saw a large decrease in short interest during the month of June. As of June 30th, there was short interest totaling 751 shares, a decrease of 84.8% from the June 15th total of 4,938 shares. Based on an average daily volume of 13,699 shares, the days-to-cover ratio is currently 0.1 days.
Fortress Biotech Stock Down 1.3%
NASDAQ:FBIOP traded down $0.24 on Friday, hitting $18.56. The stock had a trading volume of 8,330 shares, compared to its average volume of 23,866. The business’s fifty day moving average is $18.37 and its 200 day moving average is $14.51. Fortress Biotech has a 52 week low of $6.27 and a 52 week high of $21.43.
Fortress Biotech Company Profile
Fortress Biotech, Inc (NASDAQ: FBIOP) is a biopharmaceutical company that acquires, develops and commercializes innovative therapeutics for the treatment of patients with serious diseases. Operating as a biotech accelerator, Fortress Biotech partners with experienced management teams to advance products from early-stage discovery through regulatory approval and commercial launch. Its diversified portfolio spans multiple therapeutic areas, including oncology, rare diseases, dermatology, ophthalmology and neuromuscular disorders.
The company’s business model centers on establishing and funding product-centric subsidiary companies, each focused on a specific drug candidate or therapy.
Featured Stories
- Five stocks we like better than Fortress Biotech
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
